Announcement of the 2022 first quarter consolidated financial report approved by the Board of Directors
· Issued by Taiyen Biotech Co. Ltd.
Close
Today's Information
Provided by: Taiyen Biotech Co.,Ltd
SEQ_NO
1
Date of announcement
2022/04/29
Time of announcement
13:58:12
Subject
Announcement of the 2022 first quarter consolidated
financial report approved by the Board of Directors
Date of events
2022/04/29
To which item it meets
paragraph 31
Statement
1.Date of submission to the board of directors or approval by the board of
directors:2022/04/29
2.Date of approval by the audit committee:2022/04/29
3.Start and end dates of financial reports or annual self-assessed financial
information of the reporting period (XXXX/XX/XX~XXXX/XX/XX):2022/01/01~
2022/03/31
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):923,153
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):327,670
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):131,549
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):164,949
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):131,736
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):127,238
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):0.64
11.Total assets end of the period (thousand NTD):8,477,185
12.Total liabilities end of the period
(thousand NTD):1,831,209
13.Equity attributable to owners of parent end of the
period (thousand NTD):6,489,275
14.Any other matters that need to be specified:None
